Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 93 300 KRW 0.65% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Chong Kun Dang Pharmaceutical Corp?
Write Note

Chong Kun Dang Pharmaceutical Corp
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chong Kun Dang Pharmaceutical Corp
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Accrued Liabilities
â‚©27.5B
CAGR 3-Years
26%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Accrued Liabilities
â‚©37.5B
CAGR 3-Years
213%
CAGR 5-Years
36%
CAGR 10-Years
48%
SK Biopharmaceuticals Co Ltd
KRX:326030
Accrued Liabilities
â‚©71.3B
CAGR 3-Years
25%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Accrued Liabilities
â‚©52.7B
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Accrued Liabilities
â‚©10.9B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Accrued Liabilities
â‚©313m
CAGR 3-Years
-47%
CAGR 5-Years
-26%
CAGR 10-Years
-17%
No Stocks Found

Chong Kun Dang Pharmaceutical Corp
Glance View

Market Cap
1.2T KRW
Industry
Pharmaceuticals

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Intrinsic Value
97 275.99 KRW
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Chong Kun Dang Pharmaceutical Corp's Accrued Liabilities?
Accrued Liabilities
27.5B KRW

Based on the financial report for Dec 31, 2023, Chong Kun Dang Pharmaceutical Corp's Accrued Liabilities amounts to 27.5B KRW.

What is Chong Kun Dang Pharmaceutical Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
6%

Over the last year, the Accrued Liabilities growth was 38%. The average annual Accrued Liabilities growth rates for Chong Kun Dang Pharmaceutical Corp have been 26% over the past three years , 6% over the past five years .

Back to Top